Atlas Trials

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Clinical trial NCT04095208 · COMPLETED

Trial details

NCT number
NCT04095208
Sponsor
Institut Bergonié
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Soft Tissue Sarcoma AdultAdvanced Cancer
Start date
2020-02-27
Primary completion
2024-09-29
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.